Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,879 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Serum amyloid A and lipoprotein retention in murine models of atherosclerosis.
O'Brien KD, McDonald TO, Kunjathoor V, Eng K, Knopp EA, Lewis K, Lopez R, Kirk EA, Chait A, Wight TN, deBeer FC, LeBoeuf RC. O'Brien KD, et al. Among authors: lopez r. Arterioscler Thromb Vasc Biol. 2005 Apr;25(4):785-90. doi: 10.1161/01.ATV.0000158383.65277.2b. Epub 2005 Feb 3. Arterioscler Thromb Vasc Biol. 2005. PMID: 15692094
Defining and benchmarking open problems in single-cell analysis.
Luecken MD, Gigante S, Burkhardt DB, Cannoodt R, Strobl DC, Markov NS, Zappia L, Palla G, Lewis W, Dimitrov D, Vinyard ME, Magruder DS, Mueller MF, Andersson A, Dann E, Qin Q, Otto DJ, Klein M, Botvinnik OB, Deconinck L, Waldrant K, Yasa SN, Szałata A, Benz A, Li Z; Open Problems Jamboree Members; Bloom JM, Pisco AO, Saez-Rodriguez J, Wulsin D, Pinello L, Saeys Y, Theis FJ, Krishnaswamy S. Luecken MD, et al. Nat Biotechnol. 2025 Jul 1. doi: 10.1038/s41587-025-02694-w. Online ahead of print. Nat Biotechnol. 2025. PMID: 40595413 No abstract available.
Time-to-event analysis mitigates the impact of symptomatic therapy on therapeutic benefit in Parkinson's disease trials.
Pagano G, Trundell D, Simuni T, Pavese N, Marek K, Postuma RB, Shariati N, Monnet A, Moore E, Davies EW, Svoboda H, Pross N, Bonni A, Nikolcheva T; PASADENA Investigators; Prasinezumab Study Group. Pagano G, et al. NPJ Parkinsons Dis. 2025 Jul 1;11(1):193. doi: 10.1038/s41531-025-01041-9. NPJ Parkinsons Dis. 2025. PMID: 40593721 Free PMC article.
The role of innate immune responses against two strains of PEDV (S INDEL and non-S INDEL) in newborn and weaned piglets inoculated by combined orogastric and intranasal routes.
López-Figueroa C, Cano E, Navarro N, Pérez M, López R, Skovgaard K, Vorsholt H, Heegaard PMH, Vergara-Alert J, Segalés J. López-Figueroa C, et al. Among authors: lopez r. Front Immunol. 2025 Jun 16;16:1584785. doi: 10.3389/fimmu.2025.1584785. eCollection 2025. Front Immunol. 2025. PMID: 40589734 Free PMC article.
Identification of phenotypes and predictors for dyspnea, echocardiographic probability of pulmonary hypertension, and confirmed CTEPH in patients with acute pulmonary embolism: Analysis of two large patient cohorts.
Mendoza-Zambrano E, Ballaz-Quincoces A, Lobo JL, Gomez-Cuervo C, Lopez R, Marchena-Yglesias PJ, Fernández C, Lopez-Miguel P, Jimenez D, Francisco-Albesa I, Alfonso M, Pedrajas-Navas JM, Lumbierres-Burgues M, Núñez-Ares A, Aibar-Arregui MA, Rodriguez-Matute C, Lopez-Saez JB, de Miguel-Díez J, Perez-Pinar M, Barca-Hernando M, Klok FA, Monreal M, Andrade-Ruiz H, González-Acosta M, Otero-Candelera R, Jara-Palomares L; Osiris and Sysppe Investigators. Mendoza-Zambrano E, et al. Among authors: lopez r. Thromb Res. 2025 Aug;252:109379. doi: 10.1016/j.thromres.2025.109379. Epub 2025 Jun 13. Thromb Res. 2025. PMID: 40577990 No abstract available.
3,879 results